Abstract:BACKGROUND:Due to the high heterogeneity of lung adenocarcinoma (LUAD), which restricts the effectiveness of therapy, precise molecular subgrouping of LUAD is of great significance. Clinical research has demonstrated the significant potential of DNA methylation as a classification indicator for human malignancies.METHODS:WGML framework (which was developed based on weighted gene correlation network analysis (WGCNA), Gene Ontology (GO), and machine learning) was developed to precisely subgroup molecular subtypes of LUAD. This framework included two parts: the WG algorithm and the machine learning part. The WG algorithm part was an original algorithm used to obtain a crucial module, which was characterized by weighted correlation network analysis, functional annotation, and mathematical algorithms. The machine learning part utilized the Boruta algorithm, random forest algorithm, and Gradient Boosting Regression Tree algorithm to select feature genes. Then, based on the results of the WGML framework, subtypes were computed by the hierarchical clustering algorithm. A series of analyses, including dimensionality reduction methods, survival analysis, clinical stage analysis, immune infiltration analysis, tumor environment analysis, immune checkpoints analysis, TIDE analysis, CYT analysis, somatic mutation analysis, and drug sensitivity analysis, were utilized to demonstrate the effectiveness of subgrouping. GEO datasets were used to externally validate the results. Meanwhile, another subgrouping method of LUAD from another study was employed to compare with the WGML framework.RESULT:By importing DNA methylation data into the WGML framework, nine genes were obtained to further subgroup LUAD. Three subtypes, the Carcinogenesis subtype, Immune-infiltration subtype, and Chemoresistance subtype, were identified. The dimensionality reduction method exhibited great distinctness between subtypes. A series of analyses were employed to exhibit the difference among the three subtypes and to demonstrate the accuracy of the definition of subtypes. Besides, the WGML framework was compared with a LUAD subgrouping method from another research, which demonstrated that WGML had better efficiency for subgrouping LUAD.CONCLUSION:This study provides a novel LUAD subgrouping framework named WGML for the accurate subgrouping of lung adenocarcinoma.

Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients

Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma

Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

Identification of molecular subtypes in lung adenocarcinoma based on DNA methylation and gene expression profiling—a bioinformatic analysis

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method

Precise Molecular Subtyping Reveals Heterogeneity of Lung Adenocarcinoma Based on DNA Methylation.

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients

A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis

DNA methylation data–based molecular subtype classification related to the prognosis of patients with cervical cancer

Specific Breast Cancer Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.

Prognostic Analysis of Lung Adenocarcinoma Based on DNA Methylation Regulatory Factor Clustering

DNA Methylation Analysis Identifies Clinically Relevant Lung Adenocarcinoma Subgroups

A Functional Methylation Signature to Predict the Prognosis of Chinese Lung Adenocarcinoma Based on TCGA

Identification of a Novel CpG Methylation Signature to Predict Prognosis in Lung Squamous Cell Carcinoma

A prognostic 11-DNA methylation signature for lung squamous cell carcinoma

Novel Methylation-Driven Genes Identified As Prognostic Indicators for Lung Squamous Cell Carcinoma